Biomea Fusion BMEA
NASDAQ BMEA
$0.74 -0.10 (-11.96%)
At close: Oct 20, 2026 · 4:00 PM EDT

Biomea Fusion (BMEA) Receivables (2020 - 2021)

Updated

Biomea Fusion's Receivables was $36,000 in Q1 2021, up 50.0% from the prior quarter.

Analysis

Biomea Fusion (BMEA) Receivables (2020 - 2021) Analysis & Trends

At the end of FY2020, Receivables at Biomea Fusion came in at $24,000.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Receivables (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn 23.48 Bn
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn 19.05 Bn
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn 13.82 Bn
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn 12.56 Bn
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn 9.64 Bn
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn 15.68 Bn
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn 10.23 Bn
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn 5.06 Bn
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn 12.49 Bn
10 Biomea Fusion 53.98 Mn -128.36 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2021 36,000.00
Dec 31, 2020 24,000.00
API Access

Biomea Fusion Receivables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables&ticker=BMEA&period=max&api_key=YOUR_API_KEY